IMU-based Assessment of Motor Control in a Population of Young Subjects With Paramorphisms and Dysmorphisms
Launched by ISTITUTO ORTOPEDICO RIZZOLI · Feb 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how certain common physical conditions, called "paramorphisms" and "dysmorphisms," affect the way children move and control their bodies. Conditions like flat feet, bow legs (genu varum), and knock knees (genu valgus) are examples of what the researchers are studying. The goal is to compare the movement control of children with these conditions to that of healthy children to see if there are any differences in how they develop motor skills.
To be eligible for the study, participants need to be children born at full term who do not have any known delays in their movement development, but who do have one or more of the mentioned physical conditions. Children with preterm birth or serious motor control issues, like cerebral palsy, will not be included. Those who take part can expect to undergo clinical tests and use wearable devices that track their movement. This research could help us better understand how these common conditions impact children's ability to move and develop physically.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Born at term
- • Without known delay in motor development
- • Finding of one or more paramorphisms or dysmorphisms of the developmental age (flat or cavus foot, valgus or varus talipes, valgus or varus knee, scoliotic attitude or scoliosis, hyperkyphosis or hyperlordosis, generalized or focused hyperlaxity, heterometry of the AAII, torsional defects AAII)
- Exclusion Criteria:
- • Preterm birth
- • Diagnosis of pathologies compromising motor control (Infantile Cerebral Palsy, Neuromuscular Diseases, Spina Bifida, Arthrogryposis, Genetic Syndromes)
About Istituto Ortopedico Rizzoli
Istituto Ortopedico Rizzoli is a renowned orthopedic research and treatment institute based in Bologna, Italy, dedicated to advancing musculoskeletal health through innovative clinical trials and cutting-edge medical practices. With a strong emphasis on research, the institute collaborates with leading experts in orthopedics, rehabilitation, and related fields to develop and evaluate new therapies and surgical techniques. Committed to improving patient outcomes, Istituto Ortopedico Rizzoli not only focuses on high-quality clinical care but also fosters a robust research environment that supports the translation of scientific findings into clinical applications.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bologna, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials